Study touts use of FDG-PET in treating Peutz-Jeghers syndrome

06/18/2009 | (free registration)

Researchers used FDG-PET to monitor the effectivity of a class of drugs called rapamycin analogs in treating Peutz-Jeghers syndrome, a rare genetic disease that increases a patient's risk of colon cancer. Polyps in mice were found to have a high FDG uptake, suggesting that the drug could be used in the future to control lesion growth, and that "FDG-PET may find clinical utility for the identification of polyps in [Peutz-Jeghers syndrome] patients," the researchers said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN